Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Piramal Pharma Limited ( (IN:PPLPHARMA) ) has issued an update.
Piramal Pharma Limited successfully conducted its 5th Annual General Meeting (AGM) on July 30, 2025, via video conference, ensuring compliance with regulatory guidelines. All proposed resolutions were passed with the requisite majority, demonstrating strong shareholder support and effective governance practices. The AGM proceedings were webcast for transparency, and e-voting facilities were provided to facilitate shareholder participation, reflecting the company’s commitment to leveraging technology for stakeholder engagement.
More about Piramal Pharma Limited
Piramal Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its comprehensive product portfolio and services, catering to various market needs in the healthcare sector.
Average Trading Volume: 244,227
Technical Sentiment Signal: Hold
Current Market Cap: 271.6B INR
Learn more about PPLPHARMA stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money